In vitro effect of Triac on resistance to thyroid hormone receptor mutants: Potential basis for therapy

Molecular and Cellular Endocrinology

Volumn 174, Issue 1-2, 2001, Pages 59-69

  Messier, N ^a   Laflamme, L ^a   Hamann, G ^a   Langlois, M F ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Gene regulation; Resistance to thyroid hormone; Thyroid hormone receptor (human); Thyroid hormone response element; Triiodothyroacetic acid; Triiodothyronine

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROID HORMONE RECEPTOR; TIRATRICOL;

ANIMAL CELL; BINDING AFFINITY; CONCENTRATION RESPONSE; DEFENSE MECHANISM; DRUG RECEPTOR BINDING; EXON; GENE CONTROL; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; MONKEY; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; THYROID HORMONE RESISTANCE; TRANSCRIPTION REGULATION;

EID: 0035961981     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(00)00446-9     Document Type: Article

References (80)

1. Divergent roles for thyroid hormone receptor β isoforms in the endocrine axis and auditory system
2. Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone
3. Prenatal diagnosis of thyroid hormone resistance
4. Molecular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site
5. Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3′-triiodothyroacetic acid (TRIAC)
6. Dissociated thyromimetic effects of 3,5,3′-triiodothyroacetic acid (TRIAC) at the pituitary and peripheral tissue levels
7. A point mutation (Ala229 to Thr) in the hinge domain of the c-erbA beta thyroid hormone receptor gene in a family with generalized thyroid hormone resistance
8. Comparison of the metabolic and endocrine effects of 3,5,3′-triiodothyroacetic acid and thyroxine
9. Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors
10. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome
11. A role for helix 3 of the TRβ ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone
12. Expression of thyroid hormone receptor beta 2 in rat hypothalamus
13. Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone
14. Uptake of 3,3′,5,5′-tetraiodothyroacetic acid and 3,3′,5′-triiodothyronine in cultured rat anterior pituitary cells and their effects on thyrotropin secretion
15. Inappropriate secretion of thyrotropin by the pituitary
16. A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition
17. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor β: evidence for tissue-specific modulation of receptor function
18. Comparison of the metabolism and distribution of L-triiodothyronine and triiodothyroacetic acid in the rat: a possible explanation of differential hormonal potency
19. Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors?
20. Identification of a thyroid hormone receptor that is pituitary-specific
21. Ligand-independent and -dependent functions of thyroid hormone receptor isoforms depend upon their distinct amino termini
22. Value of triiodothyroacetic acid as suppressive treatment of the thyrotropin secretion in thyroid pathology
23. 3,5,3′-triiodothyroacetic acid therapy for thyroid hormone resistance
24. A unique role of the beta-2 thyroid hormone receptor isoform in negative regulation by thyroid hormone. Mapping of a novel amino-terminal domain important for ligand-independent activation
25. Thyroid hormone receptors: multiple forms, multiple possibilities
26. Immunocytochemical delineation of thyroid hormone receptor beta 2-like immunoreactivity in the rat central nervous system
27. Identification of thyroid hormone receptor isoforms in thyrotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus
28. Detection of extended distribution of beta2-thyroid hormone receptor messenger ribonucleic acid (RNA) in adult rat brain using complementary RNA in situ hybridization histochemistry
29. Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors
30. Nuclear receptor that identifies a novel retinoic acid response pathway
31. TRIAC (3,5,3′-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine
32. Triac (3,5,3′-triiodothyroacetic acid) partially inhibits the thyrotropin response to synthetic thyrotropin-releasing hormone in normal and thyroidectomized hypothyroid patients
33. Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3′-triiodothyronine receptors from four families with generalized resistance to thyroid hormone
34. 3 response element-dependent dominant negative potency
35. Triac regulation of transcription is T3 receptor isoform- and response element-specific
36. Identification of a novel mutation in the gene encoding the beta-triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormone
37. Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA
38. 3,5,3′-Triiodothyroacetic acid minimizes the pituitary thyrotrophin secretion in patients on levo-thyroxine therapy after ablative therapy for differentiated thyroid carcinoma
39. Isolation and characterization of rat cDNA clones for two distinct thyroid hormone receptors
40. Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations
41. Requirement of corepressor binding of thyroid hormone receptor mutants for dominant negative inhibition
42. Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance
43. Thyroid hormone receptor mutants that cause resistance to thyroid hormone: evidence for receptor competition for DNA sequences in target genes
44. Characterization of a thyroid hormone receptor expressed in human kidney and other tissues
45. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone
46. Thyroid hormone response element architecture affects corepressor release from thyroid hormone receptor dimers
47. A novel point mutation (R243Q) in exon 7 of the c-erbA beta thyroid hormone receptor gene in a family with resistance to thyroid hormone
48. Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two 'hot spot' regions of the ligand binding domain
49. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene
50. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs
51. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance
52. The syndromes of resistance to thyroid hormone
53. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone
54. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone
55. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone
56. Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta
57. 3), bromocriptine and Triac on inappropriate TSH hypersecretion
58. Pituitary resistance to thyroid hormone associated with a base mutation in the hormone-binding domain of the human 3,5,3′-triiodothyronine receptor-beta
59. Widespread distribution of immunoreactive thyroid hormone beta 2 receptor (TR beta 2) in the nuclei of extrapituitary rat tissues
60. Organ-specific effects of tiratricol: a thyroid hormone analog with hepatic, not pituitary, superagonist effects
61. Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxine
62. Limited capacity binding sites for L-triiodothyronine in rat liver nuclei. Localization to the chromatin and partial characterization of the L-triiodothyronine-chromatin complex
63. Two thyroid hormone response elements are present in the promoter of human thyroid hormone receptor beta 1
64. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone
65. Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous system
66. Differences in response of thyrotropin to 3,5,3′-triiodothyronine and 3,5,3′-triiodothyroacetic acid in patients with resistance to thyroid hormone
67. Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene
68. A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor
69. A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds
70. Multiple genetic factors in the heterogeneity of thyroid hormone resistance
71. Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families
72. Thyrotropin regulation by thyroid hormone in thyroid hormone receptor β-deficient mice
73. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor α1
74. Isolation and characterization of mouse complementary DNAs encoding alpha and beta thyroid hormone receptors from thyrotrope cells: the mouse pituitary-specific beta 2 isoform differs at the amino terminus from the corresponding species from rat pituitary tumor cells
75. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3′-triiodothyroinine binding affinity
76. Molecular mechanisms of dominant negative activity by nuclear hormone receptors
77. 3 receptors and transcriptional corepressors
78. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific